NT5C1B

gene
On this page

Also known as AIRPCN-IB

Summary

NT5C1B (5’-nucleotidase, cytosolic IB, HGNC:17818) is a protein-coding gene on chromosome 2p24.2, encoding Cytosolic 5’-nucleotidase 1B (Q96P26). Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, AMP is the major substrate.

Cytosolic 5-prime nucleotidases, such as NT5C1B, catalyze production of adenosine, which regulates diverse physiologic processes (Sala-Newby and Newby, 2001 [PubMed 11690631]).

Source: NCBI Gene 93034 — RefSeq curated summary.

At a glance

  • GWAS associations: 18
  • Clinical variants (ClinVar): 109 total
  • MANE Select transcript: NM_033253

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17818
Approved symbolNT5C1B
Name5’-nucleotidase, cytosolic IB
Location2p24.2
Locus typegene with protein product
StatusApproved
AliasesAIRP, CN-IB
Ensembl geneENSG00000185013
Ensembl biotypeprotein_coding
OMIM610526
Entrez93034

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 4 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000304081, ENST00000359846, ENST00000406971, ENST00000416783, ENST00000418427, ENST00000460052, ENST00000490687

RefSeq mRNA: 5 — MANE Select: NM_033253 NM_001002006, NM_001199086, NM_001199087, NM_001199088, NM_033253

CCDS: CCDS33149, CCDS33150

Canonical transcript exons

ENST00000304081 — 9 exons

ExonStartEnd
ENSE000019458961858943918589569
ENSE000034674681858750318587592
ENSE000035334961858286818582997
ENSE000035602881858408818584255
ENSE000035668001857618418576368
ENSE000036774361858451418584978
ENSE000036826871857677318576895
ENSE000036879551858625418586391
ENSE000039781211856287118564119

Expression profiles

Bgee: expression breadth ubiquitous, 157 present calls, max score 99.56.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0088 / max 7.2174, expressed in 3 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
270500.08873
270490.00883

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001999.56gold quality
left testisUBERON:000453391.03gold quality
right testisUBERON:000453490.83gold quality
testisUBERON:000047388.34gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.06gold quality
adult organismUBERON:000702382.64gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099174.01gold quality
tibialis anteriorUBERON:000138571.51silver quality
pancreatic ductal cellCL:000207969.52silver quality
right coronary arteryUBERON:000162568.34gold quality
right lobe of liverUBERON:000111467.83gold quality
lower esophagusUBERON:001347367.60gold quality
lower esophagus muscularis layerUBERON:003583367.54gold quality
islet of LangerhansUBERON:000000667.11gold quality
ileal mucosaUBERON:000033166.22gold quality
olfactory segment of nasal mucosaUBERON:000538666.22gold quality
esophagusUBERON:000104365.37gold quality
rectumUBERON:000105265.33gold quality
esophagogastric junction muscularis propriaUBERON:003584164.34gold quality
esophagus mucosaUBERON:000246963.60gold quality
lower esophagus mucosaUBERON:003583463.56gold quality
body of stomachUBERON:000116163.44gold quality
descending thoracic aortaUBERON:000234562.73gold quality
apex of heartUBERON:000209862.49gold quality
stomachUBERON:000094562.10gold quality
thoracic aortaUBERON:000151561.94gold quality
ascending aortaUBERON:000149661.88gold quality
skin of abdomenUBERON:000141661.87gold quality
tibial arteryUBERON:000761061.87gold quality
popliteal arteryUBERON:000225061.81gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

31 targeting NT5C1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-570-3P99.9672.414910
HSA-MIR-368699.9070.532432
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-5580-3P99.7069.412052
HSA-MIR-58799.6470.862611
HSA-MIR-5197-5P99.6469.081494
HSA-MIR-4756-3P99.6266.301319
HSA-MIR-1212299.5669.331672
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-3616-5P99.5567.02989
HSA-MIR-57399.5567.44955
HSA-MIR-467299.5071.582893
HSA-MIR-451999.4866.10859
HSA-MIR-653-5P99.4667.351300
HSA-MIR-4652-3P99.3370.022742
HSA-MIR-122B-3P99.2168.901333
HSA-MIR-21-3P99.2168.951312
HSA-MIR-4795-5P99.1166.90876
HSA-MIR-42198.9067.041883
HSA-MIR-4764-5P98.8865.53894
HSA-MIR-316198.7167.14816
HSA-MIR-427498.5966.10630
HSA-MIR-548AO-5P98.5569.571362
HSA-MIR-548AX98.5569.581362
HSA-MIR-4709-5P98.5167.251335
HSA-MIR-7114-5P98.5167.871349
HSA-MIR-118296.4164.89336

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriont5c1baENSDARG00000018153
danio_reriont5c1bbENSDARG00000033742
mus_musculusNt5c1bENSMUSG00000020622
rattus_norvegicusNt5c1bENSRNOG00000004296

Paralogs (1): NT5C1A (ENSG00000116981)

Protein

Protein identifiers

Cytosolic 5’-nucleotidase 1BQ96P26 (reviewed: Q96P26)

Alternative names: Autoimmune infertility-related protein, Cytosolic 5’-nucleotidase IB

All UniProt accessions (5): Q96P26, A0A140VJC7, C4AM88, C9JW75, H7BZQ4

UniProt curated annotations — full annotation on UniProt →

Function. Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, AMP is the major substrate.

Subcellular location. Cytoplasm.

Tissue specificity. Highly expressed in testis, placenta and pancreas. Detected at lower levels in heart, kidney, liver and lung.

Activity regulation. Activated by ADP.

Similarity. Belongs to the 5’-nucleotidase type 3 family.

Isoforms (4)

UniProt IDNamesCanonical?
Q96P26-11, CN-Ib alphayes
Q96P26-22
Q96P26-33
Q96P26-44

RefSeq proteins (5): NP_001002006, NP_001186015, NP_001186016, NP_001186017, NP_150278* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR0103945-nucleotidaseFamily

Pfam: PF06189

Catalyzed reactions (Rhea), 2 shown:

  • a ribonucleoside 5’-phosphate + H2O = a ribonucleoside + phosphate (RHEA:12484)
  • AMP + H2O = adenosine + phosphate (RHEA:29375)

UniProt features (19 total): sequence conflict 7, compositionally biased region 5, splice variant 3, region of interest 2, chain 1, active site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96P26-F163.860.31

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 467 (nucleophile)

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-74259Purine catabolism
R-HSA-1430728Metabolism
R-HSA-15869Metabolism of nucleotides
R-HSA-8956319Nucleotide catabolism

MSigDB gene sets: 59 (showing top): GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, BRN2_01, GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS, TGANTCA_AP1_C, TGACATY_UNKNOWN, KEGG_PURINE_METABOLISM, GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS, AFFAR_YY1_TARGETS_DN, GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS, FOX_Q2, EVI1_04, GOMF_MAGNESIUM_ION_BINDING

GO Biological Process (3): purine nucleotide catabolic process (GO:0006195), adenosine metabolic process (GO:0046085), nucleotide metabolic process (GO:0009117)

GO Molecular Function (4): nucleotide binding (GO:0000166), magnesium ion binding (GO:0000287), 5’-nucleotidase activity (GO:0008253), hydrolase activity (GO:0016787)

GO Cellular Component (3): nucleus (GO:0005634), cytosol (GO:0005829), cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
Nucleotide catabolism1
Metabolism1
Metabolism of nucleotides1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
purine nucleotide metabolic process1
nucleotide catabolic process1
purine-containing compound catabolic process1
purine ribonucleoside metabolic process1
nucleoside phosphate metabolic process1
nucleoside phosphate binding1
heterocyclic compound binding1
metal ion binding1
nucleotidase activity1
catalytic activity1
intracellular membrane-bounded organelle1
cytoplasm1
intracellular anatomical structure1

Protein interactions and networks

STRING

1741 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NT5C1BNT5MQ9NPB1627
NT5C1BNT5C3BQ969T7599
NT5C1BNT5CQ8TCD5598
NT5C1BNT5C2P49902523
NT5C1BTMEM202A6NGA9516
NT5C1BLKAAEAR1Q8TD35506
NT5C1BNT5C3AQ9H0P0492
NT5C1BEFCAB10A6NFE3471
NT5C1BNME6O75414461
NT5C1BSPEM3A0A1B0GUW6448
NT5C1BSPATA31F1Q6ZU69447
NT5C1BC4orf17Q53FE4433
NT5C1BDUXBA0A1W2PPF3425
NT5C1BPRR30Q53SZ7421
NT5C1BGARIN3Q8TC56419

IntAct

0 interactions, top by confidence:

BioGRID (4): NT5C1B (Affinity Capture-MS), NT5C1B (Affinity Capture-MS), NT5C1B (Cross-Linking-MS (XL-MS)), NT5C1B (Reconstituted Complex)

ESM2 similar proteins: A0A2R8VHF7, A0JM23, A2QRA0, A4IIA7, A4IIV4, A6NFN9, A6NHR9, A7MBF6, F4IG73, F4JSE7, O17482, O95876, P12540, P21784, P34089, P38899, P55895, P56696, Q08AW4, Q0D2D7, Q12789, Q13829, Q28DC9, Q2WGJ8, Q3E7Y5, Q3UUE9, Q4R907, Q4VXA5, Q5BK83, Q5EA90, Q5F476, Q5HZS2, Q5M9F0, Q5RAX4, Q5RBH4, Q5RD21, Q6AYL6, Q6DGA7, Q6PIY5, Q70XZ2

Diamond homologs: A3KFX0, Q91YE9, Q96P26, Q9BXI3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

109 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance100
Likely benign6
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

1519 predictions. Top by Δscore:

VariantEffectΔscore
2:18584082:GAATA:Gdonor_loss1.0000
2:18584083:AATAC:Adonor_loss1.0000
2:18584084:ATAC:Adonor_loss1.0000
2:18584085:TAC:Tdonor_loss1.0000
2:18584087:C:Adonor_loss1.0000
2:18587594:T:Cacceptor_gain1.0000
2:18576179:CCTA:Cdonor_loss0.9900
2:18576180:CTA:Cdonor_loss0.9900
2:18576181:TA:Tdonor_loss0.9900
2:18576182:A:Cdonor_loss0.9900
2:18576183:C:Gdonor_loss0.9900
2:18576199:A:ACdonor_gain0.9900
2:18576200:C:CCdonor_gain0.9900
2:18576202:TTC:Tdonor_gain0.9900
2:18576219:A:ACdonor_gain0.9900
2:18576220:C:CCdonor_gain0.9900
2:18576366:TAC:Tacceptor_gain0.9900
2:18576366:TACCT:Tacceptor_loss0.9900
2:18576367:ACCT:Aacceptor_loss0.9900
2:18576368:CCT:Cacceptor_loss0.9900
2:18576369:C:Aacceptor_loss0.9900
2:18576370:T:Gacceptor_loss0.9900
2:18576372:A:Cacceptor_gain0.9900
2:18576775:T:Adonor_gain0.9900
2:18582862:ACTT:Adonor_loss0.9900
2:18582863:CTTA:Cdonor_loss0.9900
2:18582864:TTAC:Tdonor_loss0.9900
2:18582865:TACC:Tdonor_loss0.9900
2:18582866:ACCGT:Adonor_loss0.9900
2:18582867:C:CTdonor_loss0.9900

AlphaMissense

3587 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:18563966:A:GW555R0.994
2:18563966:A:TW555R0.994
2:18582881:G:CS396R0.987
2:18582881:G:TS396R0.987
2:18582883:T:GS396R0.987
2:18563937:G:CF564L0.986
2:18563937:G:TF564L0.986
2:18563939:A:GF564L0.986
2:18564069:G:CF520L0.986
2:18564069:G:TF520L0.986
2:18564071:A:GF520L0.986
2:18576299:G:TA465D0.982
2:18584205:G:CF318L0.981
2:18584205:G:TF318L0.981
2:18584207:A:GF318L0.981
2:18563974:A:GL552P0.980
2:18563974:A:TL552H0.980
2:18564025:A:GL535P0.980
2:18563893:G:TP579H0.979
2:18563964:C:AW555C0.979
2:18563964:C:GW555C0.979
2:18576296:A:GF466S0.979
2:18563938:A:GF564S0.978
2:18564029:A:CY534D0.978
2:18576295:A:CF466L0.976
2:18576295:A:TF466L0.976
2:18576297:A:GF466L0.976
2:18564078:T:AQ517H0.974
2:18564078:T:GQ517H0.974
2:18563983:A:GL549P0.973

dbSNP variants (sampled 300 via entrez): RS1000006558 (2:18570024 G>A), RS1000043575 (2:18581243 A>G), RS1000108601 (2:18562599 G>A), RS1000203703 (2:18587249 TC>T,TCC,TCCC), RS1000247039 (2:18588162 A>G,T), RS1000602565 (2:18579642 A>G), RS1000856533 (2:18577697 A>G), RS1000956543 (2:18585926 TC>T), RS1001343705 (2:18563535 A>G,T), RS1001428896 (2:18583725 G>A), RS1001608798 (2:18588398 A>G), RS1001638934 (2:18583162 T>C), RS1001708307 (2:18588710 G>A), RS1001763612 (2:18589044 G>A,T), RS1002099141 (2:18590625 G>T)

Disease associations

OMIM: gene MIM:610526 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

18 associations (top):

StudyTraitp-value
GCST001958_19Bulimia nervosa1.000000e-07
GCST003991_8Childhood ear infection2.000000e-10
GCST004031_6QT interval (sulfonylurea treatment interaction)8.000000e-08
GCST006479_142Diverticular disease4.000000e-08
GCST006624_64Systolic blood pressure2.000000e-12
GCST007344_14Estimated glomerular filtration rate1.000000e-08
GCST008747_67Estimated glomerular filtration rate4.000000e-13
GCST009723_91Vertical cup-disc ratio (adjusted for vertical disc diameter)3.000000e-06
GCST009723_99Vertical cup-disc ratio (adjusted for vertical disc diameter)3.000000e-06
GCST009724_90Vertical cup-disc ratio (multi-trait analysis)1.000000e-09
GCST009724_91Vertical cup-disc ratio (multi-trait analysis)8.000000e-09
GCST010697_8Cortical surface area (min-P)9.000000e-11
GCST010698_76Subcortical volume (min-P)6.000000e-13
GCST010699_22Brain morphology (min-P)9.000000e-10
GCST010700_49Cortical thickness (MOSTest)2.000000e-10
GCST010701_21Cortical surface area (MOSTest)1.000000e-76
GCST010702_13Subcortical volume (MOSTest)4.000000e-08
GCST010703_331Brain morphology (MOSTest)2.000000e-10

EFO canonical traits (8, from GWAS)

EFO IDTrait name
EFO:0007904susceptibility to childhood ear infection measurement
EFO:0004682QT interval
EFO:0007922response to sulfonylurea
EFO:0009959diverticular disease
EFO:0006335systolic blood pressure
EFO:0006939cup-to-disc ratio measurement
EFO:0004346neuroimaging measurement
EFO:0004840cortical thickness

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: enzyme — Adenosine turnover

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases methylation1
Grape Seed Proanthocyanidinsaffects cotreatment, decreases expression1
bisphenol Sdecreases methylation1
Fulvestrantaffects cotreatment, increases methylation1
Benzo(a)pyreneincreases expression1
Catechinaffects cotreatment, decreases expression1
Valproic Aciddecreases methylation1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bulimia nervosa